U. Emmenegger Cancer Research Laboratory

Sunnybrook Health Sciences Centre, Toronto, Ontario
What the facility does

Chemo sensitivity testing of cancer cells in vitro and in vivo, chemo resistance studies, autophagy studies, bone metastasis research, biomarker discovery

Area(s) of Expertise

The U. Emmenegger Cancer Research Laboratory’s clinical and research concerns focus on systemic therapy of castration-resistant prostate cancer.
We also focus on biomarker research and the development of novel therapies, especially anti-angiogenic therapies (such as metronomic chemotherapy), autophagy modulation, and FGF23.FGFR pathway inhibition. We are interested  in drug-drug interactions with respect to novel prostate cancer therapies.

Research Services

In vitro and in vivo drug testing.

Sectors of Application
  • Healthcare and social services
  • Life sciences, pharmaceuticals and medical equipment

Name of specialized lab

Name of equipment

Description of function

U. Emmenegger

Hypoxia incubator

To study the role of hypoxia on drug sensitivity

  • Preclinical and clinical collaborations with a number of pharmaceutical companies.